Search Orphan Drug Designations and Approvals
-
| Generic Name: | small molecule inhibitor of PRMT5 (protein arginine methyl transferase 5) |
|---|---|
| Date Designated: | 11/27/2024 |
| Orphan Designation: | treatment of MTAP-deleted pancreatic cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Tango Therapeutics, Inc. 201 Brookline Avenue, Suite 901 Boston, Massachusetts 02215 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







